Acadia Healthcare Company (ACHC) Cash & Equivalents (2010 - 2026)

Acadia Healthcare Company (ACHC) has 17 years of Cash & Equivalents data on file, last reported at $158.5 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $158.5 million, up 73.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $158.5 million (up 73.69% YoY), and the FY2025 annual result was $133.2 million, up 74.62% from the prior year.
• Cash & Equivalents advanced to $158.5 million in Q1 2026 per ACHC's latest filing, from $133.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $158.5 million in Q1 2026 and troughed at $63.8 million in Q1 2023.
• A 5-year average of $104.8 million and a median of $99.6 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents plunged 54.53% in 2023, then soared 74.62% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $97.6 million in 2022, then increased by 2.48% to $100.1 million in 2023, then decreased by 23.75% to $76.3 million in 2024, then soared by 74.62% to $133.2 million in 2025, then increased by 18.94% to $158.5 million in 2026.
• Business Quant data shows ACHC's Cash & Equivalents at $158.5 million in Q1 2026, $133.2 million in Q4 2025, and $118.7 million in Q3 2025.